Media Releases

Quick Explore

Media Releases 2024
Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India
Cipla signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India
Cipla EU to invest an additional EUR 3 million in Ethris
Cipla receives final approval for the generic version of Somatuline® Depot (lanreotide) Injection 120 mg/ 0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL
Cipla announces additional investment in Achira
Cipla Health strengthens its play in beauty and personal care
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India
Cipla strengthens fight against AMR, secures approval to introduce ZEMDRI® (plazomicin) injection in India
Cipla partners with CSIR-CDRI to advance Ophthalmic Antifungal Treatment Development
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products